This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...

Gov. Gavin Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the drug. The project is years away from delivering medicine to anyone, ...

It also caps insulin ... could impact drug prices by curbing research into cost-reduction models and suggests that reducing drug prices is not a priority for the Trump administration.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...

During his first term, Trump did establish a voluntary, time-limited model capping insulin costs at $35 per month for people on participating Medicare Part D prescription drug plans. KFF ...